| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tango Therapeutics, Inc. | Other* | Common Stock | 108,793 | $944,323 | $8.68 | 02 Jul 2024 | Direct |
| Tyra Biosciences, Inc. | 10%+ Owner | Common Stock | 22,527 | $148,205 | $6.58 | 10 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | 28 Jun 2024 | 3 | -$2,055,314 | 4 | Other* | 02 Jul 2024, 20:56 |
| TNGX | Tango Therapeutics, Inc. | 06 Jun 2024 | 2 | -$985,880 | 4 | Other* | 07 Jun 2024, 21:14 |
| TNGX | Tango Therapeutics, Inc. | 01 May 2024 | 3 | -$1,580,850 | 4 | Other* | 03 May 2024, 21:34 |
| TYRA | Tyra Biosciences, Inc. | 09 Feb 2023 | 2 | -$3,498,611 | 4 | 10%+ Owner | 13 Feb 2023, 20:39 |